Company: AEMD
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001683168-25-006049
Chunk: 1

Company: AETHLON MEDICAL INC
Filing Date: 2025-08-13
Form: 10-Q
Item: Item 1
Chunk 1
---

shares issued and 2,010,739 outstanding at March
31, 2025. 
     2,599  
     2,586 
  
    Additional paid-in capital 
     173,159,966  
     173,092,894 
  
    Accumulated other comprehensive loss 
     (22,377) 
     (17,133)
  
    Accumulated deficit 
     (169,716,675) 
     (167,954,817)

    Total stockholders’ equity 
     3,423,513  
     5,123,530 

    Total liabilities and stockholders’ equity 
    $5,306,002  
    $7,359,534 

The accompanying notes are an integral part of these
condensed consolidated financial statements.

 4 

AETHLON MEDICAL, INC. AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

For the Three Month Periods Ended June 30, 2025 and
2024

(Unaudited)

    Three Months  Ended  June 30,  2025  
    Three Months  Ended  June 30,  2024 

    OPERATING EXPENSES 

    Professional fees 
    $476,032  
    $614,082 
  
    Payroll and related expenses 
     581,000  
     1,254,802 
  
    General and administrative 
     735,358  
     751,974 
  
    Total operating expenses 
     1,792,390  
     2,620,858 
  
    OPERATING LOSS 
     (1,792,390) 
     (2,620,858)

    OTHER (EXPENSE) INCOME, NET 

    Interest income 
     36,466  
     49,418 
  
    Other 
     (5,934) 
     – 

    NET LOSS 
     (1,761,858) 
     (2,571,440)

    NET LOSS ATTRIBUTABLE TO AETHLON MEDICAL, INC. 
     (1,761,858) 
     (2,571,440)

    OTHER COMPREHENSIVE LOSS 
     (5,244) 
     (833)

    COMPREHENSIVE LOSS 
    $(